To assess the pivotal role of PD-1 expressing CD8+ T cell subsets in conferring long-term protection against tumors, we conducted a rechallenge experiment using MC38-p53KO/E285K tumor models treated with LNP-pE285K-mAb, αPD-1 or their combination. The gene discussed is CD8A; the disease is neoplasm.